Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nanocurcumin and chlorhexidine mouthwash on salivary Streptococcus mutans in fixed orthodontic patients
IRCT20220223054108N3Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of nanocurcumin and chlorhexidine in Oral bacterial infection and carious lesion (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoint: Change in salivary Streptococcus mutans level. Started Feb 2025; status: completed.
02
Drugs
nanocurcuminchlorhexidine
03
Conditions
Oral bacterial infectioncarious lesion
Beyond the preview
Go deeper on IRCT20220223054108N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220223054108N3.